Cellebrite DI Ltd. has announced that its shareholders have approved all proposals presented at the company's annual general meeting held on September 19, 2025. The meeting saw participation from holders of 188,039,771 ordinary shares, which accounts for approximately 76.82% of the issued and outstanding ordinary shares as of the record date. The approvals were granted by the requisite majority as stipulated by the Israeli Companies Law and the company's articles of association. This information was disclosed in a report on Form 6-K, which is incorporated by reference into Cellebrite's registration statements filed with the Securities and Exchange Commission (SEC).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-089834), on September 22, 2025, and is solely responsible for the information contained therein.